Parastoo Khoshakhlagh

Parastoo Khoshakhlagh, Ph.D. currently serves as CEO & Co-Founder at GC Therapeutics since April 2019. Additionally, Parastoo holds the position of Member of Board Of Directors & Co-Founder, as well as CSO and Co-Founder at Tympanogen since January 2014. Parastoo has a background as a Postdoctoral Research Fellow at the Wyss Institute for Biologically Inspired Engineering at Harvard Medical School and at Harvard-MIT Health Sciences and Technology. Parastoo also completed a Mini-MBA course at Harvard Business School in 2015. Parastoo completed their Doctor of Philosophy degree in Biomedical Engineering/Neural Engineering from Tulane University.